Advertisement

Topics

Regeneron rises as revenue and earnings exceed estimates

13:18 EST 8 Nov 2017 | thePharmaLetter

Better-than-expected third-quarter financial results at Regeneron Pharmaceuticals sent its share price

Original Article: Regeneron rises as revenue and earnings exceed estimates

NEXT ARTICLE

More From BioPortfolio on "Regeneron rises as revenue and earnings exceed estimates"

Advertisement
Quick Search
Advertisement
Advertisement